Ascorbate Plus Buformin in AML: A Metabolic Targeted Treatment
In the present study, we characterized the metabolic background of different Acute Myeloid Leukemias’ (AMLs) cells and described a heterogeneous and highly flexible energetic metabolism. Using the Seahorse XF Agilent, we compared the metabolism of normal hematopoietic progenitors with that of primar...
Main Authors: | Cristina Banella, Gianfranco Catalano, Serena Travaglini, Elvira Pelosi, Tiziana Ottone, Alessandra Zaza, Gisella Guerrera, Daniela Francesca Angelini, Pasquale Niscola, Mariadomenica Divona, Luca Battistini, Maria Screnci, Emanuele Ammatuna, Ugo Testa, Clara Nervi, Maria Teresa Voso, Nelida Ines Noguera |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-05-01
|
Series: | Cancers |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6694/14/10/2565 |
Similar Items
-
Buformin suppresses osteosarcoma via targeting AMPK signaling pathway
by: Ding Yan, et al.
Published: (2020-06-01) -
Determination of CAR T cell metabolism in an optimized protocol
by: Sandy Joaquina, et al.
Published: (2023-06-01) -
Triggering Apoptotic Death of Human Epidermal Keratinocytes by Malic Acid: Involvement of Endoplasmic Reticulum Stress- and Mitochondria-Dependent Signaling Pathways
by: Yu-Ping Hsiao, et al.
Published: (2015-01-01) -
Neutral Sphingomyelinase-2 (NSM 2) Controls T Cell Metabolic Homeostasis and Reprogramming During Activation
by: Maria Nathalia De Lira, et al.
Published: (2020-09-01) -
PML/RARa Interferes with NRF2 Transcriptional Activity Increasing the Sensitivity to Ascorbate of Acute Promyelocytic Leukemia Cells
by: Cristina Banella, et al.
Published: (2019-12-01)